Huntington National Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240M Buy
260,694
+2,647
+1% +$2.68M 1.32% 14
2025
Q4
$277M Sell
258,047
-4,009
-2% -$3.83M 1.66% 11
2025
Q3
$200M Sell
262,056
-9,415
-3% -$7.01M 1.22% 15
2025
Q2
$212M Sell
271,471
-8,167
-3% -$6.35M 1.39% 13
2025
Q1
$231M Sell
279,638
-6,671
-2% -$5.55M 1.67% 10
2024
Q4
$221M Sell
286,309
-11,140
-4% -$9.22M 1.58% 13
2024
Q3
$264M Buy
297,449
+595
+0.2% +$535K 1.92% 6
2024
Q2
$269M Sell
296,854
-8,858
-3% -$7.09M 2.08% 6
2024
Q1
$238M Buy
305,712
+3,478
+1% +$2.48M 1.91% 7
2023
Q4
$176M Sell
302,234
-5,232
-2% -$3.05M 1.6% 11
2023
Q3
$165M Sell
307,466
-9,396
-3% -$4.84M 1.66% 10
2023
Q2
$149M Buy
316,862
+36,448
+13% +$15.3M 1.38% 14
2023
Q1
$96.3M Sell
280,414
-2,232
-0.8% -$753K 0.96% 26
2022
Q4
$103M Buy
282,646
+898
+0.3% +$318K 1.08% 26
2022
Q3
$91.1M Buy
281,748
+446
+0.2% +$141K 1.04% 24
2022
Q2
$91.2M Buy
281,302
+9,689
+4% +$2.91M 0.98% 27
2022
Q1
$77.8M Buy
271,613
+17,095
+7% +$4.4M 0.72% 36
2021
Q4
$70.3M Buy
254,518
+13,156
+5% +$3.34M 0.64% 42
2021
Q3
$55.8M Buy
241,362
+2,760
+1% +$681K 0.56% 54
2021
Q2
$54.8M Buy
238,602
+11,807
+5% +$2.37M 0.55% 56
2021
Q1
$42.4M Buy
226,795
+9,817
+5% +$1.92M 0.51% 65
2020
Q4
$36.6M Buy
216,978
+3,383
+2% +$505K 0.48% 67
2020
Q3
$31.6M Buy
213,595
+8,789
+4% +$1.36M 0.46% 70
2020
Q2
$33.6M Buy
204,806
+47,129
+30% +$7.23M 0.53% 60
2020
Q1
$21.9M Buy
157,677
+57,043
+57% +$7.84M 0.41% 75
2019
Q4
$13.2M Sell
100,634
-4,360
-4% -$505K 0.2% 124
2019
Q3
$11.7M Sell
104,994
-3,402
-3% -$379K 0.19% 124
2019
Q2
$12M Buy
108,396
+179
+0.2% +$21.1K 0.19% 127
2019
Q1
$14M Sell
108,217
-3,608
-3% -$439K 0.23% 118
2018
Q4
$12.9M Sell
111,825
-51,417
-31% -$5.74M 0.23% 123
2018
Q3
$17.5M Sell
163,242
-3,116
-2% -$312K 0.27% 108
2018
Q2
$14.2M Sell
166,358
-1,474
-0.9% -$121K 0.24% 122
2018
Q1
$13M Sell
167,832
-10,795
-6% -$869K 0.22% 129
2017
Q4
$15.1M Sell
178,627
-6,754
-4% -$575K 0.24% 122
2017
Q3
$15.9M Buy
185,381
+2,986
+2% +$245K 0.27% 118
2017
Q2
$15M Sell
182,395
-7,657
-4% -$625K 0.26% 117
2017
Q1
$16M Buy
190,052
+1,061
+0.6% +$85K 0.28% 111
2016
Q4
$13.9M Sell
188,991
-3,068
-2% -$228K 0.25% 113
2016
Q3
$15.4M Buy
192,059
+19,464
+11% +$1.56M 0.29% 109
2016
Q2
$13.6M Sell
172,595
-18,773
-10% -$1.41M 0.34% 96
2016
Q1
$13.9M Buy
191,368
+12,318
+7% +$932K 0.34% 93
2015
Q4
$15.1M Sell
179,050
-3,801
-2% -$315K 0.38% 88
2015
Q3
$15.3M Sell
182,851
-2,138
-1% -$180K 0.4% 80
2015
Q2
$15.4M Sell
184,989
-6,379
-3% -$486K 0.37% 89
2015
Q1
$13.9M Sell
191,368
-7,605
-4% -$541K 0.34% 93
2014
Q4
$13.7M Sell
198,973
-5,425
-3% -$366K 0.33% 95
2014
Q3
$13.3M Sell
204,398
-5,000
-2% -$317K 0.27% 101
2014
Q2
$13M Sell
209,398
-9,788
-4% -$584K 0.26% 106
2014
Q1
$12.9M Buy
219,186
+17,520
+9% +$978K 0.25% 101
2013
Q4
$10.3M Buy
201,666
+38,900
+24% +$1.95M 0.27% 110
2013
Q3
$8.19M Sell
162,766
-5,308
-3% -$278K 0.24% 117
2013
Q2
$8.26M Buy
+168,074
New +$9.15M 0.26% 110

Other funds holding LLY

Huntington National Bank's LLY Position: Q1 2026 in Review

Huntington National Bank increased its Eli Lilly (LLY) stake by 1% in Q1 2026, buying an estimated $2.68M and bringing the position to 260,694 shares worth $240M. The position accounts for 1.32% of the portfolio, ranked #14.

Huntington National Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $277M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Huntington National Bank held 260,694 shares of Eli Lilly worth $240M as of Q1 2026.
  • Huntington National Bank bought 2,647 Eli Lilly shares in Q1 2026, an estimated $2.68M.
  • Eli Lilly made up 1.32% of Huntington National Bank's portfolio in Q1 2026, its #14 holding.
  • Huntington National Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Huntington National Bank's Eli Lilly position peaked at $277M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.